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228Objective: Transoral incisionless fundoplication (TIF) is a promising approach for gastroesophageal reflux dis-
ease (GERD) that may decrease morbidity compared with conventional antireflux procedures. We report our
initial experience with this minimally invasive approach.
Methods:Over a 24-month period, 46 patients (mean age, 49 years; 50% female) underwent 48 TIF procedures.
All procedures were performed under general anesthesia. Two surgeons participated in all cases; one served as
the endoscopist, and the other performed the partial fundoplication. Heartburn severity was measured using the
GERD health-related quality of life (GERD-HRQL) instrument (best score ¼ 0, worst score ¼ 45), which in-
cludes an additional question assessing overall satisfaction.
Results: Preoperatively, 33 (72%) of 46 patients had small (<3 cm) hiatal hernias, and none had undergone any
previous antireflux procedures. Preoperative workup included manometry and barium esophagogram, with pH
testing reserved for patients with atypical symptoms or typical symptoms and a lack of response to proton-pump
inhibitors. The mean procedure time was 83 minutes (range, 36-180 minutes). The mean procedure time de-
creased after the first 5 cases from 122 to 78 minutes (P ¼ .001). Mean length of stay was 1.3 days. One patient
was readmitted with aspiration pneumonia. Three patients had minor complications (1 had minor bleeding from
a suture site and 2 had urinary retention). Therewere no perioperative deaths. Mean follow-up was 140 days. The
mean GERD-HRQL scores improved significantly (23 vs 7; P<.001). There were 22 patients with follow-up
greater than 90 days (mean follow-up, 240 days). GERD-HRQL scores remained significantly improved for
these patients (23 vs 8; P¼ .001). Four patients from the entire group (8.6%) had no improvement, in 3 instances
due to breakdown of the wrap. Two patients were treated with repeat endoscopic fundoplication and 1 was
treated with laparoscopic Nissen fundoplication, and all had a significant improvement in symptoms after
reoperation.
Conclusions: TIF is effective at short-term follow-up and safe for patients with GERD. However, long-term fol-
low-up and randomized trials are required to assess the efficacy and durability of this approach compared with
conventional surgical repair. (J Thorac Cardiovasc Surg 2012;143:228-34)Gastroesophageal reflux disease (GERD) is a common con-
dition that is encountered in primary care practices through-
out the United States.1 Although proton pump inhibitors
(PPIs) constitute the primary treatment for most patients
with GERD,2,3 for those patients who have complications
such as erosive esophagitis or Barrett’s metaplasia, have
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The Journal of Thoracic and Cardiovascular Surgtherapy, surgical intervention with a laparoscopic Nissen
fundoplication is the conventional approach. Although it
has been associated with great efficacy in treating reflux
in patients with either typical or atypical symptoms,4,5 it
may lead to postoperative symptoms such as dysphagia
and bloating,6-8 and may have poorer outcomes when
performed in low-volume centers.9
Endoscopic fundoplication, also known as transoral inci-
sionless fundoplication (TIF), is an antireflux procedure
that uses a proprietary device (EsophyX2; EndoGastric So-
lutions, Redmond, Wash), which is approved by the Food
and Drug Administration for the treatment of gastroesoph-
ageal reflux disease. This procedure creates a fold around
the distal intra-abdominal esophagus, forming a valve that
is similar physiologically to a partial fundoplication.10 It
can be used in patients with small hiatal hernias. Although
it has already been used in some European centers, few
North American reports have been published.11-14
The purpose of this study is to review our initial results
with endoscopic fundoplication for the treatment of GERD.ery c January 2012
Abbreviations and Acronyms
GERD ¼ gastroesophageal reflux disease
HRQL ¼ health-related quality of life
LES ¼ lower esophageal sphincter
PPI ¼ proton pump inhibitor
TIF ¼ transoral incisionless fundoplication
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Patient Selection
Patients with typical or atypical symptoms deemed to be related to gas-
troesophageal reflux disease were considered for endoscopic fundoplica-
tion. The presence of a hiatal hernia greater than 3 cm or a previous
antireflux operation were considered exclusion criteria. Preoperative
workup included a careful history and completion of the GERD health-
related quality of life (GERD-HRQL) survey, a 9-item questionnaire that
has previously been validated.15 Scores were expressed on a scale from
0 to 45, where 45 represented the worst possible score. An additional ques-
tion assessed overall satisfaction.
All patients underwent upper endoscopy, esophageal manometry, and
barium esophagogram. For patients with typical reflux symptoms without
response to medications or with atypical reflux symptoms, esophageal pH
or impedance testing was performed to confirm the presence of reflux be-
fore endoscopic fundoplication.E
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All procedures were performed in the operating room with general en-
dotracheal anesthesia. Patients were positioned in the left lateral decubitus
position. A bite-block device was placed in the mouth. An initial esopha-
gogastroduodenoscopy was performed, which served several purposes:
(1) it allowed the surgeon to directly assess the esophagus for the presence
of pathologic conditions (such as Barrett’s esophagus or hiatal hernia); (2)
it allowed for the assignment of a Hill score16 based on the shape of the gas-
troesophageal junction when viewed on retroflexion; and (3) it allowed the
surgeon to determine whether the stomach was completely evacuated of
foodmaterial. After the suitability of each patient was confirmed endoscop-
ically, the EsophyX2 device (Figure 1, A and B) was prepared for use on the
back table.
The EsophyX2 device has a tubular shape and slips over an endoscope.
On the end that is inserted into the alimentary tract (Figure 1, B), it has
a helical retractor that is advanced and anchored to the Z-line
(Figure 2, A). Downward traction on the Z-line with the helical retractor
helps to reconstitute the angle of His, which contributes to the antireflux
mechanism. The gastric fundus is approximated to the distal intra-
abdominal esophagus by closure of the tissue mold (Figure 2, B). In cases
in which a small hiatal hernia is present, suction can be applied along the
shaft of the device, bringing the esophagus into close apposition with the
device. As traction is also maintained distally with the helical retractor at
the gastroesophageal junction, when the whole device is advanced into the
mouth and esophagus, small hiatal hernias can be reduced before fundo-
plication. Two stylets are used to deploy 2 polypropylene sutures, fash-
ioned as H-shaped fasteners, that anchor the fundus to the esophagus
(Figure 2, C). Sutures are placed along 2 semicircumferential rows oppo-
site to the lesser curvature, 1 proximal to the other, until an omega-shaped
wrap of 270 and 2-cm length is created (Figure 3). This procedure typ-
ically requires approximately 12 to 20 sutures and excludes the lesser cur-
vature to avoid injury to the vagus nerves. Although a small hiatal hernia
may be reduced during the creation of the wrap, herniorrhaphy is not
achievable with this technique.The Journal of Thoracic and CaOne surgeon acts as an endoscopist and the other operates the device
during each procedure. Visibility is optimized by insufflating the stomach
with carbon dioxide gas from a laparoscopic insufflation system that is set
to a pressure between 12 and 15 mmHg, and complete muscle relaxation is
achieved with the administration of a paralytic medication. After the wrap
is completed and the device is removed, endoscopy is repeated to evacuate
air and accumulated secretions and to inspect the valve. Generally, we do
not place a nasogastric tube.
All patients are observed overnight, undergo a barium esophagogram
the following morning to evaluate for a leak (on account of the extent of
manipulation about the gastroesophageal junction), and are discharged af-
ter starting liquids. Patients are followed up at 2 to 4 weeks, 6 to 8 weeks, 3
months, 6 months, and yearly. At all follow-up visits, we routinely use the
GERD-HRQL survey to monitor their symptom severity and satisfaction.
Data Collection and Statistical Analysis
This study was approved by our institutional review board. Data were
collected through a retrospective chart review using a data collection
form that queried demographic and preoperative clinical information, stud-
ies performed as part of each patient’s workup, and data from the perioper-
ative and follow-up periods. Statistical analysis was conducted using the
SPSS (version 11 for Windows) statistical software package (SPSS, Inc,
Chicago, Ill). Descriptive statistics included mean and median values for
numerical data. Paired sample t-tests were used to compare preoperative
and most recent follow-up GERD-HRQL scores.
RESULTS
From February 2009 through January 2011, a total of 46
patients underwent 48 endoscopic fundoplication proce-
dures. The mean and median ages were 49 and 48 years
(range, 23-84 years), respectively, and 50% were women.
For all patients, the mean and median American Society
of Anesthesiologists scores were both 2 (range, 1-3). Thirty-
five (76.1%) patients had typical symptoms (ie, heartburn,
regurgitation, or water brash) and the remaining 11 had
atypical symptoms (ie, cough, rhinitis, asthma, or aspira-
tion). All patients with atypical symptoms had objective
confirmation of reflux with pH or impedance testing. Six pa-
tients had dysphagia preoperatively, and 42 had been using
PPIs daily. The mean and median preoperative GERD-
HRQL scores were 23.2 and 23, respectively. Twenty-two
patients underwent pH probe evaluation. Thirty-three pa-
tients were found to have small hiatal hernias; the remaining
patients had no hiatal hernias. The mean and median Hill
scores were both 3 (range, 2-4).
The mean procedure time for endoscopic fundoplication
was 83 minutes (range, 36-180 minutes). In comparing
mean procedure times for the first 5 patients to the subse-
quent 41 patients, there was a significant difference (122
vs 78 minutes; P ¼ .001).
The mean hospital length of stay was 1.3 days (range, 1-3
days).Onepatient had evidence of pneumoperitoneumon the
immediate postoperative chest x-ray. There was no clinical
evidence of peritonitis or perforation, which was confirmed
by barium esophagogram. The patient was discharged on
the second postoperative day without an incident.
There was one major complication in a patient who was
readmitted postoperatively with an aspiration pneumonia,rdiovascular Surgery c Volume 143, Number 1 229
FIGURE 1. The EsophyX2 device. A, Handle. B, End. (Courtesy of EndoGastric Solutions, Inc, Redmond, Wash.)
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S which was due to perioperative nausea and vomiting after
recovery from anesthesia for the procedure. She subse-
quently recovered and remains symptom-free. There
were 3 minor complications. One patient had bleeding230 The Journal of Thoracic and Cardiovascular Surgfrom a suture site during the procedure. This was con-
trolled with compression using the device for a few min-
utes and did not require a blood transfusion or an
additional intervention. Also, 2 patients had postoperativeery c January 2012
FIGURE 2. A, Helical retractor retracting the Z-line into the tissue mold. B, Tissue mold closed to approximate the fundus to the intra-abdominal esoph-
agus. C, Placement of polypropylene H-fastners to secure the fundoplication (Courtesy of EndoGastric Solutions, Inc, Redmond, Wash.).
Narsule et al Evolving Technology/Basic Scienceurinary retention requiring catheterization. There were no
postoperative deaths.
The mean and median follow-up times were 140 and 83
days, respectively (range, 15-602 days). At follow-up, there
was a significant difference between the preoperative and
postoperative mean GERD-HRQL scores (23 vs 6.7;
P< .001) and the number of patients using PPIs (91.3%
vs 47.8%; P< .001). Before therapy, 95.7% of patients
were dissatisfied with their condition compared with 13%
(6 patients) postoperatively (P< .001). Among the 6 pa-
tients who remained dissatisfied postoperatively, 4 had no
symptomatic improvement and their treatments were con-
sidered confirmed failures. These failures occurred at
a mean of 5.5 months after the procedure. Three of the 4 pa-
tients had wrap disruptions that were proven endoscopi-
cally; 2 were repaired by repeat endoluminal
fundoplication and 1 by laparoscopic Nissen fundoplica-
tion. All 3 patients had a significant improvement inFIGURE 3. Omega-shapedvalve createdafter endoluminal fundoplication,
coronal view (Courtesy of EndoGastric Solutions, Inc, Redmond, Wash.).
The Journal of Thoracic and Ca
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satisfied patient whose treatment was considered to have
failed had ongoing symptoms of reflux that was confirmed
with a postoperative pH study. Further workup was ar-
ranged, but the patient has not followed up due to other un-
related medical issues. The 2 remaining patients had normal
HRQL scores but also had symptoms of gas bloat leading to
their dissatisfaction.
Thirty-five patients had typical symptoms of GERD, and
11 patients had atypical symptoms. Among patients with
typical symptoms, a significant improvement was seen be-
tween the preoperative and postoperative mean GERD-
HRQL scores (25.3 vs 4.7; P<0.001) and satisfaction rates
(0% vs 94.3%; P< .001). Among patients with atypical
symptoms, there was no significant difference between
the preoperative and postoperative mean GERD-HRQL
scores (13.67 vs 9; P ¼ .61). However, there was a signifi-
cant improvement when comparing the preoperative and
postoperative satisfaction rates (0% vs 63.6%; P ¼ .01).
Among the 46 patients, 22 had more than 90 days of
follow-up (mean, 240 days; range, 100-602 days). In this
subset with longer follow-up, the differences between pre-
operative and postoperative mean GERD-HRQL scores
(22.1 vs 8.3; P<.005), the number of patients using PPIs
(90.9% vs 45.5%; P<.001), and the percentage of patients
that were dissatisfied (90.9% vs 13.6%; P<.001) remained
significant.
DISCUSSION
This study demonstrates that endoscopic fundoplication
can be performed safely and is effective at short-term fol-
low-up. The results of this study are similar to those of pre-
vious reports.rdiovascular Surgery c Volume 143, Number 1 231
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approach for the treatment of GERD has been the focus of
intense efforts. To decrease the compliance of the lower
esophageal sphincter (LES) to prevent reflux, strategies
such as the injection of compounds into the submucosa of
the LES,17,18 radiofrequency ablation of the submucosa of
the LES,19 mucosal plication,20 and full-thickness gastric
plication21 have all been previously attempted. Unfortu-
nately, none of these approaches has gained widespread
acceptance owing to an increased rate of complications or
recurrent symptoms.22 Perhaps what made most of these
earlier approaches less successful was that they all ulti-
mately led to a narrowing of the gastroesophageal junction,
which in itself was not enough to mitigate acid reflux. In ad-
dition, none of these approaches truly emulated a surgical
fundoplasty to restore the competency of the reflux valve.
Endoluminal fundoplication using the EsophX2 device rep-
resents the latest endoscopic approach associated with both
short-term effectiveness in treating GERD and elimination
of postoperative PPI use in several series.
One concern with endoscopic fundoplication is the dura-
bility of the procedure. With an open or laparoscopic oper-
ation, intra-abdominal adhesions form that help maintain
the configuration of the fundoplication. It is unclear whether
this occurs to the same extent with the endoscopic approach.
Jobe and colleagues23 reported their experience with endo-
luminal fundoplication in a canine model in 2008. Compar-
ing 2 techniques—fundoplication of the stomach around the
gastroesophageal junction (termed ‘‘TIF 1.0’’) and around
the distal, intra-abdominal esophagus (termed ‘‘TIF
2.0’’)—the investigators demonstrated that the latter ap-
proach enabled ‘‘ink-welling’’ of the distal esophagus into
the proximal stomach, generating a physiologic flap valve
that could more effectively pinch shut with increasing intra-
gastric pressure. They also demonstrated that the fundopli-
cation along the distal esophagus and anchored by the
polypropylene H-fasteners did indeed lead to the formation
of serosal adhesions, which in theory should help preserve
the reconstructed valve over time.
Subsequently, a group reported a clinical study involving
3 sites with a total of 19 patients. Interestingly, at 10.8
months of follow-up, more than half of all patients had an
endoscopically confirmed wrap disruption necessitating
subsequent laparoscopic fundoplication for persistent
GERD.24 It is unclear why the results of this study are infe-
rior to those reported by other investigators. One issue may
be that the wrap disruptions were related to learning curve
issues, because the study enrolled the initial clinical cases
from all 3 sites. Another factor may involve patient selec-
tion, which may affect eventual treatment outcomes. This
has yet to be teased out from larger prospective studies.
Our experience with endoscopic fundoplication suggests
that there is a learning curve associated with this technique,
at least with respect to the duration of the procedure. As232 The Journal of Thoracic and Cardiovascular Surgmentioned previously, the mean procedure time dropped
significantly when we compared our first 5 cases with the
rest of our series. Also, our technique had evolved over
time. For instance, early on in our series, distention of the
stomach with insufflated air was obtained with the endo-
scope only. Later in the series (and for most patients), the
use of insufflation with carbon dioxide gas from a laparo-
scopic insufflator system was adopted and improved endo-
scopic visualization dramatically. Additionally, we found
that the exposure achieved by our standard left lateral decu-
bitus positioning was improved by manipulating the posi-
tion of the operating room table during the procedure.
Specifically, rotating the table along the longitudinal axis
or placing it in the reverse Trendelenberg orientation was
frequently performed during the procedures. Also, we found
that the application of cricoid pressure effectively prevented
the escape of insufflated gas passing through the incompe-
tent gastroesophageal junction, which helped to maintain
the endoscopic view. Usually, after 1 or 2 sutures were
placed and the valve reconstruction was begun, cricoid pres-
sure was no longer necessary.
Another area of difficulty is manipulating the endoscope
and device within a short and narrow stomach. Recently,
a device with a smaller profile has become available that
we hope will allow for easier maneuverability in such cases.
Although patients with typical symptoms had a signifi-
cant improvement in their overall satisfaction and
GERD-HRQL score, among those with atypical symptoms,
a significant improvement was seen only in the number of
satisfied patients. This is perhaps due to the insensitivity
of the GERD-HRQL instrument in assessing atypical symp-
toms of reflux. Moreover, in this series, 3 patients experi-
enced wrap disruption. Although the current set of data
precludes a further investigation of causative factors, possi-
ble causes include (1) technical issues involving suboptimal
placement of the polypropylene H-fastners, (2) poor patient
selection (such as those with large hiatal hernias or with
a wide-open (ie, type 4 Hill) gastroesophageal valve in com-
bination with a hernia), and (3) poor patient compliance in
avoiding strenuous activity, which may affect the integrity
of the repair.
Ultimately, the gold standard to which this technique
will need to be compared is the laparoscopic Nissen fundo-
plication. In 2005, the first randomized controlled trial
comparing laparoscopic Nissen fundoplication to PPIs
demonstrated the superiority of operative intervention to
medical therapy.25 Among 109 patients treated with lapa-
roscopic Nissen fundoplication, there were no operative
deaths, but there were 4 major intraoperative complications
(2 splenic injuries, 1 esophageal injury, and 1 liver injury)
as well as 6 perioperative complications (including 3 wrap
migrations, 2 respiratory tract infections, and the inclusion
of a nasogastric tube by a wrap suture) that required 4 re-
operations. Our series of 46 patients who underwentery c January 2012
Narsule et al Evolving Technology/Basic Scienceendoscopic fundoplication compares favorably because
there were no deaths and only 1 report of pneumonia, al-
though there were 3 wrap disruptions in almost half as
many total patients as treated with laparoscopy in the
aforementioned randomized series. Laine and colleagues26
had also previously reported a prospective randomized
study comparing laparoscopic with open Nissen fundopli-
cation for patients with GERD and demonstrated no oper-
ative mortality and a mean hospital stay of 3.2 days for the
laparoscopic group and 6.4 days for the open group. Our
series is comparable, with no mortality and a mean hospital
stay of 1.3 days.
Our initial experience with endoscopic fundoplication is
currently limited to 46 patients. In addition, our follow-up is
of short duration.Moreover, although therewas a significant
reduction in the number of patients who were still taking
PPIs postoperatively, almost half of the treatment popula-
tion is still taking PPIs, either at a lower dose or at least
occasionally.
It is unlikely that endoscopic fundoplication will ever
completely replace laparoscopic fundoplication because
endoscopic fundoplication can only be used for patients
with small or no hiatal hernias. However, if results prove
to be durable, endoscopic fundoplication may become the
procedure of choice for those patients who are candidates
for this less invasive procedure. There may be other advan-
tages that may make this approach preferable for patients
with impaired esophageal motility.
In conclusion, we have demonstrated that endoscopic
fundoplication is feasible, can be performed with a low in-
cidence of complications, and is effective in a majority of
patients at short-term follow-up. Further study is needed
to define long-term outcomes and predictors of treatment
success to optimize patient selection for therapy.E
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Dr W. Randolph Chitwood, Jr (Greenville, NC). I think the
next step should be a randomized study between a laparoscopic
Nissen operation and this procedure. Do these patients have the
same postoperative characteristics as those having a laparoscopic
Nissen as far as failure to eructate?
DrNarsule. They have very similar characteristics. They some-
times have postoperative bloat that we have been able to control
with simethicone effectively thereafter.rdiovascular Surgery c Volume 143, Number 1 233
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SDr Bryan Fitch Meyers (St. Louis, Mo). There are some end
points that are often talked about around antireflux surgery, both
before and after. One is a DeMeester score or 24-hour pH monitor-
ing. I did not see any data there or for manometry. Did you observe
any objective manometric change or objective reduction in the De-
Meester score after the implementation of this device?
Dr Narsule. In this study, we did not, because we did not delib-
erately have all of our patients undergo further studies. Simply put,
after they followed up with us, we assessed the efficacy of the en-
doscopic fundoplication on the basis of their symptomatology and
their response to the HRQL survey instrument. If there were issues
of dissatisfaction or persistent symptoms, we worked them up. But
aside from that, we did not perform any additional studies.
DrMeyers.Moving forward, I think that would be an important
thing to truly demonstrate the clinical effectiveness of this therapy.
Patients who undergo this treatment want to get better, and there is
going to be a certain measurable placebo effect. The self-reported
quality of life and the rate of change in the use of PPIs are pretty
soft end points for something that could have a potentially big uti-
lization and cost associated with it.
Dr G. Hossein Almassi (Milwaukee, Wis). Nice work. I have 2
questions. How easy is it to do a redo after a failed endoscopy?
Have you had any failures and did you do a redo endoscopic Nissen
again?
Dr Narsule. The redo is very similar to the initial operation. We
were fortunate to have information as to where the wrap had dis-
rupted and, endoscopically, we were able to see the points of laxity
that occurred after the first procedure.Wewere able to target where
exactly to place the polypropylene H-fasteners. It was far easier
than we had anticipated preoperatively.234 The Journal of Thoracic and Cardiovascular SurgDr Almassi. I know gastroenterologists are not cardiologists,
but what do you think will happen in the future? Are gastroenter-
ologists going to be doing this procedure?
Dr Narsule. I do not think that the future of this procedure
would be in the hands of the gastroenterologists alone, because I
think that there is an increased complexity to performing a fundo-
plasty. There have been other endoscopic approaches to the treat-
ment of GERD, and they have not persisted. Although they tried to
decrease the compliance of the LES, perhaps because a fundoplasty
had not fully been considered with those interventions, they were
not durable. Adding a fundoplasty as part of the endoscopic ap-
proach requires the special perspective that the surgeon has in per-
forming this procedure. Although it is an endoscopic procedure, it
is a procedure that is performed along the same principles. I think
that the results will be better and more durable in the hands of
surgeons.
Dr Toni Lerut (Leuven, Belgium). I have a follow-up question
on that. In Europe, the future is already in the hands of the gastro-
enterologists, because they are doing most of these procedures. It
is so in our institution, but they do it together with us, and we do
have a similar experience. What it shows on 24-hour pH monitor-
ing is that this procedure decreases the volume of reflux, but it does
not abolish it as efficiently as after a laparoscopic Nissen proce-
dure. Would you advocate this type of procedure, for instance, in
patients with Barrett’s metaplasia?
Dr Narsule. For patients who do have Barrett’s metaplasia, de-
pending on whether it is dysplastic or not, I think that this proce-
dure would still be very applicable. In fact, 5 of our patients had
Barrett’s esophagus, had an intervention for the metaplasia, and
then subsequently underwent this procedure.ery c January 2012
